| 1. |
- Bolander, Åsa, et al.
(author)
-
Serological and immunohistochemical analysis of S100 and derivatives as markers for prognosis of newly operated malignant melanoma patients
- 2008
-
In: Melanoma research. - 0960-8931 .- 1473-5636. ; 18:6, s. 412-419
-
Journal article (peer-reviewed)abstract
- The incidence of cutaneous malignant melanoma is rising, and tumour markers are attracting attention as a possible alternative to clinical examination in the follow-up situation. S100 is the preferred marker for malignant melanoma, and correlation between serum S100 and disease relapse and survival has been reported. S100 tests previously used in clinical studies were specified poorly regarding reactivity with S100A1B and S100BB. In this study, a newly designed S100 assay (designed to measure exclusively S100A1B and S100BB) and two newly developed serological assays, S100A1B, and S100BB, were investigated postoperatively in patients undergoing radical surgery for cutaneous malignant melanoma. Additionally, immunohistochemical analysis of S100A4 was performed on the primary malignant melanoma using tissue microarrays. The primary aim of the study was to investigate whether any of these assays, either singly or in combination, can contribute additional information concerning increased risk of relapse and death because of malignant melanoma. In total, 98 patients (54 males, 44 females) with malignant melanoma were included in the study. As a continuous variable, S100BB (P=0.016) was associated statistically with increased risk of relapse; this was not the case for increased values of either S100 (P=0.11) or S100A1B (P=0.92). The Kaplan-Meier overall survival as well as disease specific survival curve for the S100 serum level demonstrated a statistically significant association with better survival if the patient had a S100 level
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
- Lipcsey, Miklos, et al.
(author)
-
The brain is a source of S100B increase during endotoxemia in the pig
- 2010
-
In: Anesthesia and Analgesia. - 0003-2999 .- 1526-7598. ; 110:1, s. 174-180
-
Journal article (peer-reviewed)abstract
- BACKGROUND:Cerebral dysfunction frequently complicates septic shock. A marker of cerebral dysfunction could be of significant value in managing sedated septic patients. Plasma S100 (S100B) proteins increase in sepsis. S100B is present not only in the brain but also in other tissues. The source of this protein has not been investigated in sepsis. Our aim in this study was to determine whether the brain is an important source of S100B in an experimental sepsis model.METHODS:Twenty-seven pigs were anesthetized and randomized to either infusion of endotoxin at the rate of 1 µg · kg-1 · h-1 (n = 19) or saline (n = 8). Catheters were inserted into a cervical artery and the superior sagittal sinus. Blood samples were collected from both sites and physiologic data were registered before the start of the endotoxin infusion and hourly during the experiment. After 6 h, the animals were killed and brain tissue samples were taken from the left hemisphere. S100B in plasma was measured by enzyme-linked immunosorbent assay. Brain tissue samples were stained with biotinylated S100B antibodies.RESULTS: In the endotoxemic animals, the arterial S100B concentration increased to 442 ± 33 and 421 ± 24 ng/L at 1 and 2 h, respectively, vs 306 ± 28 and 261 ± 25 ng/L in controls (P = 0.018 and 0.00053, respectively). Mean superior sagittal sinus S100B concentrations were higher than mean arterial concentrations at all time points in the endotoxemic animals; however, significance was only reached at 2 h (P = 0.033). The focal glial S100B expression was more intense in the endotoxemic pigs than in controls (P = 0.0047).CONCLUSIONS:Our results support the hypothesis that the brain is an important source of S100B in endotoxemia even though there may be other sources. These findings make S100B a candidate as a marker of cerebral dysfunction in septic shock.
|
|
| 5. |
- Meisl, Christina J., et al.
(author)
-
Nomograms including the UBC (R) Rapid test to detect primary bladder cancer based on a multicentre dataset
- 2022
-
In: BJU International. - : John Wiley & Sons. - 1464-4096 .- 1464-410X. ; 130:6, s. 754-763
-
Journal article (peer-reviewed)abstract
- Objectives To evaluate the clinical utility of the urinary bladder cancer antigen test UBC (R) Rapid for the diagnosis of bladder cancer (BC) and to develop and validate nomograms to identify patients at high risk of primary BC. Patients and Methods Data from 1787 patients from 13 participating centres, who were tested between 2012 and 2020, including 763 patients with BC, were analysed. Urine samples were analysed with the UBC (R) Rapid test. The nomograms were developed using data from 320 patients and externally validated using data from 274 patients. The diagnostic accuracy of the UBC (R) Rapid test was evaluated using receiver-operating characteristic curve analysis. Brier scores and calibration curves were chosen for the validation. Biopsy-proven BC was predicted using multivariate logistic regression. Results The sensitivity, specificity, and area under the curve for the UBC (R) Rapid test were 46.4%, 75.5% and 0.61 (95% confidence interval [CI] 0.58-0.64) for low-grade (LG) BC, and 70.5%, 75.5% and 0.73 (95% CI 0.70-0.76) for high-grade (HG) BC, respectively. Age, UBC (R) Rapid test results, smoking status and haematuria were identified as independent predictors of primary BC. After external validation, nomograms based on these predictors resulted in areas under the curve of 0.79 (95% CI 0.72-0.87) and 0.95 (95% CI: 0.92-0.98) for predicting LG-BC and HG-BC, respectively, showing excellent calibration associated with a higher net benefit than the UBC (R) Rapid test alone for low and medium risk levels in decision curve analysis. The R Shiny app allows the results to be explored interactively and can be accessed at www.blucab-index. net. Conclusion The UBC (R) Rapid test alone has limited clinical utility for predicting the presence of BC. However, its combined use with BC risk factors including age, smoking status and haematuria provides a fast, highly accurate and non-invasive tool for screening patients for primary LG-BC and especially primary HG-BC.
|
|
| 6. |
- Sgattoni, Giulia, et al.
(author)
-
The 2011 unrest at Katla volcano : Characterization and interpretation of the tremor sources
- 2017
-
In: Journal of Volcanology and Geothermal Research. - : ELSEVIER SCIENCE BV. - 0377-0273 .- 1872-6097. ; 338, s. 63-78
-
Journal article (peer-reviewed)abstract
- A 23-hour tremor burst was recorded on July 8-9th 2011 at the Katla subglacial volcano, one of the most active and hazardous volcanoes in Iceland. This was associated with deepening of cauldrons on the ice cap and a glacial flood that caused damage to infrastructure. Increased earthquake activity within the caldera started a few days before and lasted for months afterwards and new seismic activity started on the southern flank. No visible eruption broke the ice and the question arose as to whether this episode relates to a minor subglacial eruption with the tremor being generated by volcanic processes, or by the flood. The tremor signal consisted of bursts with varying amplitude and duration. We have identified and described three different tremor phases, based on amplitude and frequency features. A tremor phase associated with the flood was recorded only at stations closest to the river that flooded, correlating in time with rising water level observed at gauging stations. Using back-projection of double cross-correlations, two other phases have been located near the active ice cauldrons and are interpreted to be caused by volcanic or hydrothermal processes. The greatly increased seismicity and evidence of rapid melting of the glacier may be explained by a minor sub-glacial eruption. A less plausible interpretation is that the tremor was generated by hydrothermal boiling and/or explosions with no magma involved. This may have been induced by pressure drop triggered by the release of water when the glacial flood started. All interpretations require an increase of heat released by the volcano.
|
|
| 7. |
- Styrke, Johan, et al.
(author)
-
Evaluation of the diagnostic accuracy of UBC® Rapid in bladder cancer : a Swedish multicentre study
- 2017
-
In: Scandinavian journal of urology. - : Medical Journals Sweden AB. - 2168-1805 .- 2168-1813. ; 51:4, s. 293-300
-
Journal article (peer-reviewed)abstract
- Objective: The aim of this study was to determine the diagnostic accuracy of UBC® Rapid - a urine-based marker for bladder cancer - in patients with bladder cancer and controls, and to compare the test results across risk groups. Materials and methods: This prospective phase II study was conducted at four Swedish hospitals. UBC Rapid was evaluated in four groups: A, newly diagnosed bladder cancer (n=94); B, follow-up of non-muscle-invasive bladder cancer (n=75); C, benign urinary tract diseases (n=51); and D, healthy controls (n=50). Tumours were divided into high risk (carcinoma in situ, TaG3, T1, T2 and T3) and low risk (low malignant potential, TaG1 and TaG2). Urine samples were quantitatively analysed by UBC Rapid. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated based on optimal cut-off (receiver operator characteristics curve analysis). A linear regression compared the UBC Rapid results in the different risk groups. Results: The optimal cut-off was 8.1g/l. The median UBC Rapid values were 9.3g/l [interquartile range (IQR) 30.9] and 4.3g/l (IQR 7.8) in patients with positive and negative cystoscopy, respectively (p<.001). The value for group A was 15.6g/l (IQR 37.9), group B 5.6g/l (IQR 8.6), group C 5.1g/l (IQR 9.0) and group D 3.3g/l (IQR 7.1). Sensitivity was 70.8%, specificity 61.4%, PPV 71.3% and NPV 60.8%. The high-risk group had significantly higher UBC Rapid values than the low-risk group: 20.5g/l (IQR 42.2), sensitivity 79.2% and specificity 61.4% versus 7.0g/l (IQR 9.9), sensitivity 60.0% and specificity 61.4% (p=.039). Conclusions: The UBC Rapid urine-based marker for bladder cancer gave higher values in patients with positive than in those with negative cystoscopy. The diagnostic accuracy was better in patients with high-risk than in those with low-risk tumours, and was better during primary detection than during surveillance.
|
|
| 8. |
|
|
